GWS
KYNB

Glassman Wealth Services’s Kyntra Bio KYNB Stock Holding History

Glassman Wealth Services’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4
Closed -$90 – 2011
2023
Q3 		$90 Buy
+4
New +$157 ﹤0.01% 1973
2021
Q3 		– Hold
0
– – – 1660
2021
Q2 		– Hold
0
– – – 1515
2020
Q1 		– Sell
-1
Closed -$1K – 1257
2019
Q4 		$1K Buy
+1
New +$1.02K ﹤0.01% 910
2019
Q3 		– Hold
0
– – – 1142
2019
Q2 		– Sell
-1
Closed -$1.09K – 1166
2019
Q1 		$1K Buy
+1
New +$1.36K ﹤0.01% 792

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Glassman Wealth Services's KYNB Position: Q4 2023 in Review

Glassman Wealth Services sold out of Kyntra Bio (KYNB) in Q4 2023, closing a stake of 4 shares — an estimated $90 sold.

Glassman Wealth Services first reported a position in KYNB in Q1 2019 and held it in 3 quarters. The position peaked at $1K in Q4 2019. 100 funds tracked by Wall St. Rank hold KYNB as of Q4 2023.

  • Glassman Wealth Services reported no remaining Kyntra Bio position as of Q4 2023 after selling out during the quarter.
  • Glassman Wealth Services sold 4 Kyntra Bio shares in Q4 2023, an estimated $90.
  • Glassman Wealth Services first reported a position in Kyntra Bio in Q1 2019 and held it in 3 quarters.
  • Glassman Wealth Services's Kyntra Bio position peaked at $1K in Q4 2019.
  • 100 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2023.

Based on Glassman Wealth Services's 13F filing for Q4 2023, filed 12 Feb 2024.